Rofecoxib is a COX-2-selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute …

Feb 14, 2025 · Vioxx information from Drugs.com, includes Vioxx side effects, interactions, indications

ON SEPTEMBER 30, 2004, Merck & Co. withdrew its blockbuster arthritis med-ication rofecoxib (Vioxx) from the market after the drug was found to increase the risk of myocardial infarction …

Dec 23, 2025 · Vioxx was a prescription medication used to relieve signs and symptoms of arthritis (joint pain and inflammation), short-term pain in adults and painful menstrual cycles.

Aug 17, 2022 · Vioxx (Rofecoxib) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health …

Vioxx is a COX-2 selective, nonsteroidal anti-inflammatory drug (NSAID). Other COX-2 selective NSAIDs on the market at this time are Celebrex (celecoxib) and Bextra (valdecoxib).

rofecoxib, Vioxx What is rofecoxib, and how does it work (mechanism of action)? What brand names are available for rofecoxib? Is rofecoxib available as a generic drug? Do I need a …

Nov 10, 2007 · Five years after Vioxx's launch in 1999, Merck withdrew the drug from the market. By that time, Merck had sold billions of dollars worth of the painkiller worldwide.

VIOXX is used in children and adolescents, of at least 2 years of age and who weigh at least 10 kg (22 lbs.) to help relieve: JRA). VIOXX has not been studied in children with systemic typ …

OpenOChem LearnThe story of Merck’s COX-2 inhibitor, Vioxx (rofecoxib), serves as a significant case study in drug development, safety assessment, and the ethical responsibilities of …